Lina Aljuburi, PharmD, MS

Lina started her career at the FDA Office of New Drugs. Her tenure at FDA enabled her to gain a firm grasp of regulatory and scientific issues impacting drug development. From there she joined the Merck Regulatory Policy team until transitioning to her current position at Sanofi as the North America Head for the Regulatory Science and Policy team. Her goal is to collaborate with members of industry, government, patients, and all stakeholders to advance public health through bringing safe and effective new drug and biologic products to the market – efficiently!